Shi B - Search Results

1

Poziotinib-induced cutaneous adverse reactions in the treatment of non-small cell lung cancer: A case report.

Hui H, Wang M, Guo H, Wang Y, Shi B. Hui H, et al. Among authors: shi b. Int J Dermatol. 2022 Jun;61(6):769-770. doi: 10.1111/ijd.16205. Epub 2022 Apr 8. Int J Dermatol. 2022. PMID: 35394067 No abstract available.

2

Rhabdomyomatous mesenchymal hamartoma: case report and literature review.

Hao J, Diao QC, Wang SP, Liang CP, Shi BJ. Hao J, et al. Int J Dermatol. 2015 Oct;54(10):1183-5. doi: 10.1111/ijd.12076. Epub 2014 Jul 11. Int J Dermatol. 2015. PMID: 25041597 Review. No abstract available.

3

Reactive capillary hemangiomas induced by camrelizumab in a patient with hepatocarcinoma.

Zhang X, Wang M, Shi B. Zhang X, et al. Among authors: shi b. Int J Dermatol. 2021 Oct;60(10):e409-e410. doi: 10.1111/ijd.15606. Epub 2021 May 26. Int J Dermatol. 2021. PMID: 34036573 No abstract available.

4

Case report: Dupilumab for the treatment of bullous pemphigoid.

Wang M, Wang J, Shi B. Wang M, et al. Among authors: shi b. Dermatol Ther. 2022 Jul;35(7):e15541. doi: 10.1111/dth.15541. Epub 2022 May 13. Dermatol Ther. 2022. PMID: 35478478

5

Rare Case of Paraneoplastic Pemphigus Associated With Prostatic Cancer.

Hui HZ, Guo HX, Wang YJ, Shi BJ. Hui HZ, et al. Am J Dermatopathol. 2022 Dec 1;44(12):940-942. doi: 10.1097/DAD.0000000000002313. Epub 2022 Sep 27. Am J Dermatopathol. 2022. PMID: 36197045

6

A novel missense mutation in the MVK gene is associated with disseminated superficial porokeratosis.

Hui HZ, Wang YJ, Cheng JR, Mao H, Guo HX, Shi BJ. Hui HZ, et al. Int J Dermatol. 2023 Apr;62(4):e223-e225. doi: 10.1111/ijd.16493. Epub 2022 Nov 13. Int J Dermatol. 2023. PMID: 36371681 No abstract available.

7

Improvement of Refractory Chronic Actinic Dermatitis During Tofacitinib Treatment.

Wang YJ, Hui HZ, Cheng JR, Mao H, Diao QC, Shi BJ. Wang YJ, et al. Am J Ther. 2023 Nov-Dec 01;30(6):e547-e548. doi: 10.1097/MJT.0000000000001616. Epub 2023 Mar 1. Am J Ther. 2023. PMID: 36856587 No abstract available.

8

Subacute cutaneous lupus erythematosus after COVID-19 vaccine.

Wang YJ, Hui HZ, Cheng JR, Mao H, Shi BJ. Wang YJ, et al. Int J Rheum Dis. 2023 Jul;26(7):1407-1409. doi: 10.1111/1756-185X.14640. Epub 2023 Mar 7. Int J Rheum Dis. 2023. PMID: 36880735 No abstract available.

9

Rituximab for COVID-19 Vaccine-Associated Pemphigus Vulgaris.

Hui HZ, Wang YJ, Cheng JR, Mao H, Guo HX, Diao QC, Shi BJ. Hui HZ, et al. Am J Ther. 2023 Nov-Dec 01;30(6):e544-e546. doi: 10.1097/MJT.0000000000001620. Epub 2023 Mar 7. Am J Ther. 2023. PMID: 36881440 No abstract available.

10

Amivantamab (JNJ-61186372)-induced adverse cutaneous reaction.

Cheng JR, Hui HZ, Zheng J, Mao H, Wang YJ, Shi BJ. Cheng JR, et al. Indian J Dermatol Venereol Leprol. 2023 [SEASON];90(1):108-110. doi: 10.25259/IJDVL_717_2022. Indian J Dermatol Venereol Leprol. 2023. PMID: 37067106 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,621 results

Search Page

Filters